162 related articles for article (PubMed ID: 22315747)
1. Stem cells and lung diseases.
Singhal S; Achary S; Mahajan S; Wanjari A; Agarwal A
J Assoc Physicians India; 2011 Jul; 59():433-6. PubMed ID: 22315747
[TBL] [Abstract][Full Text] [Related]
2. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair.
Yamada M; Kubo H; Ishizawa K; Kobayashi S; Shinkawa M; Sasaki H
Thorax; 2005 May; 60(5):410-3. PubMed ID: 15860717
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells and inflammatory lung diseases.
Iyer SS; Co C; Rojas M
Panminerva Med; 2009 Mar; 51(1):5-16. PubMed ID: 19352305
[TBL] [Abstract][Full Text] [Related]
4. High passage number of stem cells adversely affects stem cell activation and myocardial protection.
Crisostomo PR; Wang M; Wairiuko GM; Morrell ED; Terrell AM; Seshadri P; Nam UH; Meldrum DR
Shock; 2006 Dec; 26(6):575-80. PubMed ID: 17117132
[TBL] [Abstract][Full Text] [Related]
5. Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases.
Conese M; Carbone A; Castellani S; Di Gioia S
Cells Tissues Organs; 2013; 197(6):445-73. PubMed ID: 23652321
[TBL] [Abstract][Full Text] [Related]
6. Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation.
Usami K; Mizuno H; Okada K; Narita Y; Aoki M; Kondo T; Mizuno D; Mase J; Nishiguchi H; Kagami H; Ueda M
J Biomed Mater Res A; 2009 Sep; 90(3):730-41. PubMed ID: 18570318
[TBL] [Abstract][Full Text] [Related]
7. A novel hypothesis of atherosclerosis: EPCs-mediated repair-to-injury.
Zhang M; Zhou SH; Li XP; Shen XQ; Fang ZF
Med Hypotheses; 2008; 70(4):838-41. PubMed ID: 17920780
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.
Hamada H; Kim MK; Iwakura A; Ii M; Thorne T; Qin G; Asai J; Tsutsumi Y; Sekiguchi H; Silver M; Wecker A; Bord E; Zhu Y; Kishore R; Losordo DW
Circulation; 2006 Nov; 114(21):2261-70. PubMed ID: 17088460
[TBL] [Abstract][Full Text] [Related]
9. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
Reinders ME; Fibbe WE; Rabelink TJ
Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
[TBL] [Abstract][Full Text] [Related]
10. [Endothelial progenitor cells: new biomarkers and potential therapy in intensive care].
Seguin T; Braun T; Mira JP
Med Mal Infect; 2007 Jun; 37(6):305-11. PubMed ID: 17512151
[TBL] [Abstract][Full Text] [Related]
11. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model.
Kyriakou C; Rabin N; Pizzey A; Nathwani A; Yong K
Haematologica; 2008 Oct; 93(10):1457-65. PubMed ID: 18728032
[TBL] [Abstract][Full Text] [Related]
12. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
[TBL] [Abstract][Full Text] [Related]
13. Autotransplantation of circulating endothelial progenitor cells protects against lipopolysaccharide-induced acute lung injury in rabbit.
Gao X; Chen W; Liang Z; Chen L
Int Immunopharmacol; 2011 Oct; 11(10):1584-90. PubMed ID: 21628004
[TBL] [Abstract][Full Text] [Related]
14. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Volloch V; Kaplan DL
Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
[TBL] [Abstract][Full Text] [Related]
15. Concise review: mesenchymal stromal cells: potential for cardiovascular repair.
Psaltis PJ; Zannettino AC; Worthley SG; Gronthos S
Stem Cells; 2008 Sep; 26(9):2201-10. PubMed ID: 18599808
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells and their potential as cardiac therapeutics.
Pittenger MF; Martin BJ
Circ Res; 2004 Jul; 95(1):9-20. PubMed ID: 15242981
[TBL] [Abstract][Full Text] [Related]
17. Endothelial progenitor cells: characterization and role in vascular biology.
Urbich C; Dimmeler S
Circ Res; 2004 Aug; 95(4):343-53. PubMed ID: 15321944
[TBL] [Abstract][Full Text] [Related]
18. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
19. Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury.
Kumamoto M; Nishiwaki T; Matsuo N; Kimura H; Matsushima K
Eur Respir J; 2009 Sep; 34(3):740-8. PubMed ID: 19324956
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression.
Loomans CJ; Wan H; de Crom R; van Haperen R; de Boer HC; Leenen PJ; Drexhage HA; Rabelink TJ; van Zonneveld AJ; Staal FJ
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1760-7. PubMed ID: 16728651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
